Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Neutrophils are key innate immune cells involved in inflammation and tissue repair.
• Tumor cells can hijack neutrophils, altering their function to promote or inhibit cancer progression.
• Neutrophil-derived exosomes (NDEs) carry cargo like RNA and proteins that impact tumor microenvironments.

Purpose of the Study:

• To review communication pathways between tumors and neutrophils.
• To elucidate the role of NDEs in tumor growth and extracellular matrix degradation.
• To discuss therapeutic strategies involving the manipulation of NDEs.

Main Methods:

• Literature review of studies on neutrophil-tumor interactions.
• Analysis of research on exosome cargo and function.
• Exploration of therapeutic applications of engineered exosomes.

Main Results:

• Tumor-bearing hosts exhibit elevated neutrophil levels.
• NDEs can deliver molecules promoting tumor growth and matrix degradation.
• Tumor-derived exosomes can induce thrombosis via neutrophil extracellular traps.
• Immune cell-derived exosomes generally exhibit anti-tumor properties.

Conclusions:

• Understanding tumor-neutrophil crosstalk is crucial for developing novel cancer therapies.
• Targeting NDEs offers potential for precise drug delivery and cancer treatment.
• Further research is needed to fully exploit NDEs therapeutically.